ROBERT A INGRAM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT A INGRAM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT A INGRAM. ROBERT A INGRAM is a Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a Director in CREE INC ($CREE) and a Director in REGENERON PHARMACEUTICALS INC ($REGN) and a Director in Valeant Pharmaceuticals International, Inc. ($BVF) and a Director in Edwards Lifesciences Corp ($EW) and a Director in Novan, Inc. ($NOVN) and a Director in Black Diamond Therapeutics, Inc. ($BDTX).
Companies in which ROBERT A INGRAM is an Insider
Bausch Health Companies Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT A INGRAM: Director
Holdings: 89,926 shares
Latest Transaction: Jan 04 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOCRYST PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT A INGRAM: Director
Holdings: 75,013 shares
Current Value: $425,324
Latest Transaction: Mar 02 2021
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Black Diamond Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT A INGRAM: Director
Holdings: 6,182 shares
Latest Transaction: Mar 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CREE, INC.
Industry: SEMICONDUCTORS & RELATED DEVICES [3674]
Position of ROBERT A INGRAM: Director
Holdings: 77,710 shares
Current Value: $2,171,217
Latest Transaction: Oct 18 2018
$CREE Market Capitalization: $2.75B
$CREE Previous Close: $27.94
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Edwards Lifesciences Corp
Industry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
Position of ROBERT A INGRAM: Director
Holdings: 32,367 shares
Current Value: $2,936,011
Latest Transaction: May 19 2015
$EW Market Capitalization: $19.41B
$EW Previous Close: $90.71
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Novan, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT A INGRAM: Director
Holdings: 169,777 shares
Current Value: $690,992
Latest Transaction: Jul 30 2020
$NOVN Market Capitalization: $65.66M
$NOVN Previous Close: $4.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
REGENERON PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT A INGRAM: Director
Holdings: 1,500 shares
Current Value: $536,535
Latest Transaction: May 27 2015
$REGN Market Capitalization: $37.03B
$REGN Previous Close: $357.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ROBERT A INGRAM
Sentiment: All, BVF, BCRX, BDTX, CREE, EW, NOVN, REGN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2021 | BDTX | Black Diamond Ther ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 24.01 | 677 | 16,255 | 6,182 | 5.5 K to 6.2 K (+12.30 %) |
| Mar 02 2021 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 10.78 | 1,739 | 18,746 | 75,013 | 73.3 K to 75 K (+2.37 %) |
| Dec 16 2020 | BDTX | Black Diamond Ther ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 34.29 | 505 | 17,316 | 5,505 | 5 K to 5.5 K (+10.10 %) |
| Dec 02 2020 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 5.11 | 3,669 | 18,749 | 73,274 | 69.6 K to 73.3 K (+5.27 %) |
| Oct 01 2020 | BDTX | Black Diamond Ther ... | INGRAM ROBERT ALEXANDER | Director | Buy | P | 30.46 | 5,000 | 152,285 | 5,000 | 0 to 5 K |
| Sep 29 2020 | BDTX | Black Diamond Ther ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 29.65 | 29,842 | 884,815 | 29,842 | |
| Sep 02 2020 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 4.15 | 4,518 | 18,750 | 69,605 | 65.1 K to 69.6 K (+6.94 %) |